Arbutus Biopharma Corp. (ABUS)
4.18
-0.06
(-1.42%)
USD |
NASDAQ |
May 18, 13:49
Arbutus Biopharma Profit Margin (Quarterly) : 94.74% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -345.2% |
| Vertex Pharmaceuticals, Inc. | 34.24% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Amgen, Inc. | 21.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 139.4% |
| Return on Assets | 116.5% |
| Return on Invested Capital | 134.0% |
| Gross Profit Margin (Quarterly) | 99.99% |
| Operating Margin (Quarterly) | 94.41% |
| Return on Net Operating Assets | 12.60K% |